PRA Health Sciences Archives | Be Korea-savvy
PRA Health Sciences Selected by Maryland State Medical Society to Supply Remote Patient Monitoring and Telehealth Services

PRA Health Sciences Selected by Maryland State Medical Society to Supply Remote Patient Monitoring and Telehealth Services

RALEIGH, N.C. and BALTIMORE, April 13 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) and the Maryland State Medical Society (MedChi) announced today that Care Innovations, a PRA Health Sciences company, was selected by MedChi to be a preferred provider of remote patient monitoring, telehealth, and digital health services for its network of 22,000+ licensed [...]

PRA’s Remote Patient Monitoring Platform Selected by Merck KGaA, Darmstadt, Germany to Work in Combination with its Human Growth Hormone Treatment System

PRA’s Remote Patient Monitoring Platform Selected by Merck KGaA, Darmstadt, Germany to Work in Combination with its Human Growth Hormone Treatment System

RALEIGH, N.C. , April 7 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today that Merck KGaA, Darmstadt, Germany, known in the United States as EMD Serono, selected PRA’s remote patient monitoring platform to work in combination with its human growth hormone (HGH) treatment system. Under this agreement, PRA’s remote patient monitoring platform backs [...]

PRA’s Center for Rare Diseases Launches Toolkit to Identify and Mitigate Risks to Rare Disease Clinical Programs

PRA’s Center for Rare Diseases Launches Toolkit to Identify and Mitigate Risks to Rare Disease Clinical Programs

RALEIGH, N.C., March 22 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today the launch of its Patient-Centric Trial Development Toolkit, available now to clinical development sponsors focusing on rare diseases. Developed by PRA’s Center for Rare Diseases in collaboration with PRA’s Rare Disease Advisory Committee (RDAC) and other patient stakeholders, the toolkit includes [...]

PRA Health Sciences Appoints Senior FDA Official to Lead New Global Center of Excellence for Decentralized Clinical Trial Strategy

PRA Health Sciences Appoints Senior FDA Official to Lead New Global Center of Excellence for Decentralized Clinical Trial Strategy

RALEIGH, N.C. , Nov. 19 (Korea Bizwire) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the appointment of Isaac Rodriguez-Chavez, PhD, MHS, MS, as Senior Vice President, Scientific and Clinical Affairs. He will lead the company’s Global Center of Excellence for Decentralized Clinical Trial (DCT) Strategy. Dr. Rodriguez-Chavez’s responsibilities will involve the continued growth [...]

PRA Health Sciences Selected by BARDA to be a Member of its Exclusive Clinical Studies Network

PRA Health Sciences Selected by BARDA to be a Member of its Exclusive Clinical Studies Network

RALEIGH, N.C., Oct. 6 (Korea Bizwire) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today it has been selected by the Biomedical Advanced Research and Development Authority (BARDA) to be a member of its updated Clinical Studies Network (CSN). Under a Clinical Trial Planning and Execution (CTPE) contract award, PRA will serve as a valued [...]

PRA Health Sciences and Deep Lens Announce Strategic Relationship to Accelerate Patient Recruitment for Precision Cancer Trials

PRA Health Sciences and Deep Lens Announce Strategic Relationship to Accelerate Patient Recruitment for Precision Cancer Trials

RALEIGH, N.C. and COLUMBUS, Ohio, Sept. 18 (Korea Bizwire) — PRA Health Sciences, Inc. (NASDAQ: PRAH) and Deep Lens, Inc., announced today a new strategic relationship to accelerate patient access and recruitment for oncology clinical trials. The relationship brings together best-in-class technologies that improve the identification, screening, and matching of cancer patients to precision-based clinical [...]

PRA Health Sciences Ready to Navigate RACE Act Requirements for Pediatric Oncology

PRA Health Sciences Ready to Navigate RACE Act Requirements for Pediatric Oncology

RALEIGH, N.C., June 18 (Korea Bizwire) — Between 2007-2017, 78 novel adult cancer agents were approved by the U.S. Food and Drug Administration,1 but none of those drugs were researched to determine effectiveness for pediatric cancers. That is about to change on August 18 when the RACE Act – The Research to Accelerate Cures and Equity [...]

PRA Enhances COVID-19 Monitoring Program with Integration of Microsoft Healthcare Bot Service

PRA Enhances COVID-19 Monitoring Program with Integration of Microsoft Healthcare Bot Service

RALEIGH, N.C., June 12 (Korea Bizwire) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the enhancement of its commercial Health Harmony COVID-19 Monitoring Program with the integration of the Microsoft Healthcare Bot service. Users of PRA’s Health Harmony digital platform who enroll in their organization’s COVID-19 Monitoring Program can use the AI-based chatbot, which can [...]

Symphony Health to Provide Free Access to New Metys™ COVID-19 Module for U.S. based Life Sciences Industry During Pandemic

Symphony Health to Provide Free Access to New Metys™ COVID-19 Module for U.S. based Life Sciences Industry During Pandemic

RALEIGH, N.C., April 8 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today that Symphony Health, a PRA Health Sciences company, will make a 30-day license of its newly released MetysTM COVID-19 Module available to the U.S. life science industry at no charge. The COVID-19 Module within the Metys platform will provide up to three [...]